Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01692288 · ClinicalTrials.gov registry record · NA

Evaluation of the Effectiveness of a Home Visiting Program for New Parents in New Mexico

A NA study, sponsored by RAND.

Completed
Registry status
NA
Development phase
278
Enrollment target

NCT01692288: Completed NA study, sponsored by RAND.

NCT01692288 is a NA study that has completed, run by RAND. The registered enrollment target is 278 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01692288, a NA study, has completed, sponsored by RAND.

COMPLETED
Registry status
NA
Development phase
278 participants
Enrollment target

Study Summary

The purpose of this study is to determine if children and mothers who participate in the First Born® Program (FBP) experience better outcomes than they would have in the absence of the program. The evaluation employs a randomized trial design to assess the effectiveness of the FBP in the Santa Fe County, NM, site. FBP is a home visitation program that uses clinically trained professionals to provide first-time parents with information, training, and access to resources designed to promote early childhood development. Services are free and may begin at any time during pregnancy or up to two months after the baby's birth and may continue until the child is three years old. In addition, a nurse postpartum home visit is offered to the parents of all participating newborns. The FBP model builds on other home visiting and prevention programs that have been shown to improve long-term outcomes of children and their families.

Interventions

  • BEHAVIORAL First Born® Program home visiting services

Trial Details

FieldValue
Enrollment Target 278 participants
Start Date 2012-09
Est. Completion 2015-04
Phase NA
RAND

78 total trials

What the finished NCT01692288 record still lists

NCT01692288 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 1 intervention - of which First Born® Program home visiting services is the first listed.

NCT01692288 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01692288 about?

NCT01692288 is a clinical study titled "Evaluation of the Effectiveness of a Home Visiting Program for New Parents in New Mexico". The purpose of this study is to determine if children and mothers who participate in the First Born® Program (FBP) experience better outcomes than they would have in the absence of the program. The evaluation employs a randomized trial design to assess the effectiveness of the FBP in the Santa Fe Co...

What is the current status of trial NCT01692288?

This trial is currently completed. It is a NA study. The enrollment target is 278 participants. The study started on 2012-09. Estimated completion is 2015-04.

What interventions are being tested in trial NCT01692288?

The interventions under investigation include: First Born® Program home visiting services (BEHAVIORAL).

Who is sponsoring clinical trial NCT01692288?

This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01692288's enrollment target sits among peer trials

278 382nd of 2000 higher than 1,618 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04586959 · 278 participants · NA

    Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

  • NCT05010148 · 278 participants · Phase 3

    A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain

  • NCT05489237 · 278 participants · Phase 1

    First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

  • NCT05965245 · 278 participants · NA

    Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01692288, the US trial registry maintained by the National Library of Medicine. NCT01692288 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.